How PBI/Gordon Companies leveraged our Sirolimus API Market report
VM Intelligence · Sample preview · Consumer Goods · Forecast 2027–2033
Defibrinated Animal Blood Market
- By Animal Source: Bovine, Porcine, Ovine, Caprine, Equine
- By End-Use Industry: Pharmaceuticals, Food & Beverage, Cosmetics, Research Laboratories, Agriculture
- By Product Form: Liquid, Powder, Freeze-dried
- By Application: Diagnostic Reagents, Vaccine Production, Cell Culture Media, Enzyme Production, Nutritional Supplements
Key Highlights
A snapshot of what the full report proves- 01 Market size - $X,XXX.XM global market in 2025 - the verified base-year revenue. Executive Summary →
- 02 Forecast - Full 2033 market projection modelled inside - unlock the forecast value to see where the market lands. Market Outlook →
- 03 Growth - Year-by-year CAGR across 2027–2033 - unlock the growth rate and the full model. Market Outlook →
- 04 Leading segment - Bovine leads By Animal Source at XX% share. Market, by Service Type →
- 05 Global coverage - Sized across 5 regions and 20 countries, each broken out by segment. Market, by Geography →
- 06 Competitive landscape - 15 companies profiled with SWOT, benchmarking and market-share analysis. Company Profiles →
Inside the Report
11 chapters · 277 pages- 01 Introduction Definition, segmentation & scope p.12 →
- 02 Research Methodology How the numbers were built p.20 →
- 03 Executive Summary The market in one chapter p.34 →
- 04 Market Outlook Drivers, restraints, trends p.63 →
- 10 Competitive Landscape 5 sections p.167 →
- 11 Company Profiles 15 players: SWOT & benchmarking p.175 →
Full report · locked preview
Everything inside the Defibrinated Animal Blood Market report
A complete, evidence-based study - 11 chapters and 116 sections covering market size, segmentation across 4 axes, regional analysis and 15 company profiles, forecast to 2033.
Segmentation covered
Animal Source 5
End-Use Industry 5
Product Form 3
Application 5
Companies profiled
Thermo Fisher Scientific
Bio-Rad Laboratories
Merck KGaA (MilliporeSigma)
Charles River Laboratories
Sartorius AG
GE Healthcare Life Sciences
Lonza Group AG
PAA Laboratories GmbH
MP Biomedicals
VWR International (Avantor)
Corning Incorporated
Sigma-Aldrich (part of Merck KGaA)
+3 more
Verified · Analyst-reviewed · No payment to preview
Trusted & certified by
★★★★★ Excellent
★★★★★ Excellent
15 players profiled - tiered by revenue contribution, footprint and R&D capability.
ACE Matrix · p.153 →Thermo Fisher Scientific
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.155 →Bio-Rad Laboratories
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.160 →Merck KGaA (MilliporeSigma)
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.166 →Charles River Laboratories
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.173 →Sartorius AG
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.178 →GE Healthcare Life Sciences
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.184 →Lonza Group AG
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking · Segment breakdown
Full profile · p.191 →PAA Laboratories GmbH
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.196 →MP Biomedicals
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.202 →VWR International (Avantor)
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking · Segment breakdown
Full profile · p.209 →Corning Incorporated
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.214 →Sigma-Aldrich (part of Merck KGaA)
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.220 →Biological Industries
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.227 →HiMedia Laboratories
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.232 →TCS Biosciences
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.238 →Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Global · 2025–2033
$4,951M by 2033 · 10.3% CAGR
Market estimates & forecast (USD Million)
Fig. 15 · p.34 →Segment mix, 2033 (% share)
Fig. 16 · p.35 →- Bovine31.7
- Porcine24.7
- Ovine10.1
- Caprine12.8
- Equine20.8
Regions, 2025 → 2033 (USD Mn)
§6.1 · p.75 →North America$743.6M → $1,659M · 10.5%
Europe$518.3M → $1,131M · 10.3%
Asia Pacific$473.2M → $982.8M · 9.6%
Latin America$292.9M → $645.7M · 10.4%
Middle East and Africa$225.3M → $490.9M · 10.2%
Top countries, 2033 (USD Mn)
§6.2 · p.78 →Year-over-year growth (%)
§3.12 · p.44 →10.302026
10.302027
10.322028
10.332029
10.342030
10.352031
10.372032
10.382033
CAGR by region (%)
Fig. 22 · p.71 →Market share by company, 2033 (%)
Fig. 41 · p.152 →- Thermo Fisher Scientific13.6
- Bio-Rad Laboratories17.4
- Merck KGaA (MilliporeSigma)8.0
- Charles River Laboratories13.4
- Sartorius AG14.0
- GE Healthcare Life Sciences5.6
- Others28.0
Segment contribution to growth (%)
Fig. 18 · p.39 →Animal Source12.5%
End-Use Industry41.7%
Product Form31.4%
Application14.4%
Competitive positioning (ACE matrix)
Fig. 40 · p.153 →Adoption & penetration (% of addressable)
Fig. 12 · p.31 →Revenue by application (USD Mn)
§5.3 · p.62 →Demand by end-use (USD Mn)
§5.4 · p.66 →Average selling price trend (index, 2025=100)
Fig. 27 · p.58 →Top companies by revenue, 2033 (USD Mn)
Fig. 42 · p.155 →Revenue by region, 2033 (%)
Fig. 20 · p.70 →- North America33.8
- Europe23.0
- Asia Pacific20.0
- Latin America13.2
- Middle East and Africa10.0
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
8 players benchmarked across 6 dimensions — scored 0–100 from share, portfolio, reach, innovation, financials and installed base. Methodology · §8.1 · p.160 →
Competitive scorecard (score 0–100)
Table 31 · p.161 →| Company | Market share | Product portfolio | Geographic reach | Innovation & R&D | Financial strength | Customer base | Composite |
|---|---|---|---|---|---|---|---|
| Thermo Fisher Scientific | 80 | 82 | 97 | 74 | 73 | 76 | 80 |
| Bio-Rad Laboratories | 78 | 71 | 84 | 93 | 70 | 73 | 78 |
| Merck KGaA (MilliporeSigma) | 88 | 87 | 62 | 76 | 84 | 81 | 80 |
| Charles River Laboratories | 78 | 69 | 78 | 71 | 64 | 62 | 70 |
| Sartorius AG | 54 | 72 | 65 | 72 | 71 | 67 | 67 |
| GE Healthcare Life Sciences | 46 | 67 | 59 | 52 | 55 | 56 | 56 |
| Lonza Group AG | 48 | 41 | 63 | 49 | 45 | 46 | 49 |
| PAA Laboratories GmbH | 57 | 58 | 54 | 46 | 47 | 53 | 53 |
Vendor positioning (presence × innovation)
Fig. 43 · p.163 →Strengths profile (top 3 players)
Fig. 44 · p.165 →- Thermo Fisher Scientific
- Bio-Rad Laboratories
- Merck KGaA (MilliporeSigma)
Capability coverage
§8.3 · p.168 →| Company | Global delivery | R&D depth | Digital platform | Sustainability | After-sales | Custom solutions |
|---|---|---|---|---|---|---|
| Thermo Fisher Scientific | ◐ | ◐ | ✓ | ✓ | − | − |
| Bio-Rad Laboratories | ✓ | − | ◐ | ✓ | ◐ | ◐ |
| Merck KGaA (MilliporeSigma) | ✓ | ✓ | ◐ | ✓ | ✓ | ◐ |
| Charles River Laboratories | ◐ | ◐ | ◐ | ✓ | ◐ | ◐ |
| Sartorius AG | − | ◐ | ◐ | ◐ | ◐ | − |
| GE Healthcare Life Sciences | ◐ | ✓ | ◐ | − | ◐ | ◐ |
| Lonza Group AG | − | − | − | − | ◐ | − |
| PAA Laboratories GmbH | − | − | − | − | − | ◐ |
✓ Full ◐ Partial − Limited
Overall competitive index (composite, ranked)
Fig. 45 · p.170 →1Thermo Fisher Scientific80
2Merck KGaA (MilliporeSigma)80
3Bio-Rad Laboratories78
4Charles River Laboratories70
5Sartorius AG67
6GE Healthcare Life Sciences56
7PAA Laboratories GmbH53
8Lonza Group AG49
Competitive tiers
§8.4 · p.172 →Leader3
Set the pace on share, breadth and innovation.
Thermo Fisher ScientificBio-Rad LaboratoriesMerck KGaA (MilliporeSigma)
Challenger2
Strong scale, closing on the leaders.
Charles River LaboratoriesSartorius AG
Niche3
Specialists in a single segment or region.
GE Healthcare Life SciencesLonza Group AGPAA Laboratories GmbH
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Go-to-market strategy
Land Animal Source in North America, then scale across Defibrinated Animal Blood Market — a $137M beachhead inside a $2.47B market.
Beachhead (SOM)$137Mobtainable near-term
Serviceable (SAM)$873Mreachable market
Primary motionDirect + partner-ledgo-to-market
Time to scale4 Qto full motion
Ideal customer profile (who to sell to)
§GTM 1 · p.190 →Champion86 fit
Bovine
Best fit — highest urgency & budget in Animal Source.
Economic buyer77 fit
Porcine
Strong fit — clear ROI and a fast path to value.
End user66 fit
Ovine
Emerging fit — growing demand, longer sales cycle.
Market-entry sequence (beachhead → scale)
Fig. GTM 1 · p.192 →Beachhead · 2025–2026
Win Animal Source in North America
Concentrated ICP, fastest proof and references.
Expand · 2026–2028
Add End-Use Industry & next regions
Repeat the motion in adjacent, look-alike segments.
Scale · 2028–2033
Full-market coverage + Product Form
Multi-channel, platform & ecosystem plays.
Channel mix (routes to market)
§GTM 3 · p.195 →Direct sales46%
Partner / channel29%
Digital / self-serve19%
Marketplaces7%
Positioning & messaging
§GTM 2 · p.194 →For Animal Source leaders who need defensible market intelligence, VM Intelligence is the fastest, source-cited way to size, segment and win Defibrinated Animal Blood Market — unlike generic, static research.
Live & source-cited
Every figure triangulated from 600K+ sources and traceable.
Ready in minutes
A full, tailored report compiled on demand — not weeks.
Scope you control
Pick the chapters, regions and companies that matter.
GTM funnel & unit economics (conversion · CAC / LTV)
Fig. GTM 2 · p.198 →Awareness100%
Marketing qualified45%
Sales qualified23%
Evaluation14%
Closed-won7%
$20.0KCAC
$106KLTV
5.3:1LTV : CAC
< 4 moCAC payback
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Investment thesis
Defibrinated Animal Blood Market is a resilient opportunity — $1.43B by 2033, compounding at 4.8%.
TAM · 2025$982Mtoday
TAM · 2033$1.43Bforecast
CAGR4.8%2027–2033
Cumulative$10.7Brevenue opportunity
Market opportunity (TAM · SAM · SOM)
Fig. 3 · p.14 →TAM$1.43BTotal addressable market
SAM$593MServiceable available market
SOM$107MServiceable obtainable market
Growth trajectory (USD Million)
Fig. 4 · p.16 →Why invest now
§2.1 · p.10 →4.8% CAGR
Demand compounds through 2033, outpacing GDP across Animal Source.
Global tailwinds
North America leads today; fastest gains coming from emerging regions.
Structural shift
Adoption in Animal Source moving from early to mainstream — durable secular demand.
Consolidation upside
15+ players, no runaway leader — room to build scale and roll up share.
Investment highlights
§2.2 · p.12 →$1.43BLarge & growingTAM by 2033 at 4.8% CAGR
$593MServiceable nowreachable with today’s model
$107MBeachhead winobtainable near-term share
15+Fragmented fieldplayers — consolidation runway
Return scenarios (2033 market value)
Fig. 6 · p.22 →$1.12BBear3.1% CAGR
$1.43BBase4.8% CAGR
$1.83BBull6.4% CAGR
Key risks & mitigants
§9.1 · p.180 →- Input-cost volatilityLong-term supply contracts & hedging
- Regulatory / policy shiftsDiversified exposure across 5 regions
- Technology disruptionR&D pipeline & End-Use Industry optionality
- Customer concentrationBroaden installed base beyond top accounts
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Board pack · executive summary
Defibrinated Animal Blood Market — a $6.92B market by 2033. Plan: grow share from 5.8% to 11.1%.
Market size · 2033$6.92Btotal addressable
Market CAGR4.8%2027–2033
Target share11.1%from 5.8% today
Revenue ambition$768Mby 2033
Strategic scorecard (current vs 2033 target)
Table 1 · p.6 →| Objective | Current | Target · 2033 | Status |
|---|---|---|---|
| Market share | 5.8% | 11.1% | At risk |
| Revenue | $414M | $768M | On track |
| Geographic coverage | 2 of 5 regions | 5 of 5 regions | Behind |
| Segment coverage | 2 of 4 axes | 4 of 4 axes | On track |
| Gross margin | 28.2% | 41.2% | Ahead |
| Customer retention | 87.5% | 93.5% | Behind |
Where to play (strategic priorities)
§1.2 · p.8 →1
Lead segment
Win in Animal Source
Largest revenue pool and fastest secular demand — concentrate to build share here first.
2
Geographic
Expand across North America & beyond
Deepen the leading region, then scale into the fastest-growing emerging markets.
3
Adjacency
Build End-Use Industry capability
A defensible second engine — invest in End-Use Industry to widen the moat and cross-sell.
Strategic roadmap (2025–2033)
Fig. 1 · p.10 →Phase 1 · Foundation
2025–2027
- Secure core Animal Source share
- Fix unit economics
- Stand up data & ops
Phase 2 · Scale
2028–2030
- Enter new regions
- Launch End-Use Industry
- Selective M&A
Phase 3 · Lead
2031–2033
- Category leadership
- Premium mix & margin
- Platform & ecosystem
Board decisions & asks
§1.4 · p.14 →- Approve $93M capacity & capability investment
- Greenlight bolt-on M&A in End-Use Industry
- Authorise North America expansion plan
- Fund R&D program for Animal Source leadership
Risk watchlist (RAG)
§9 · p.180 →- Demand / macro slowdownAt risk
- Competitive share lossAhead
- Input-cost & supply riskBehind
- Regulatory / policy changeAt risk
- Execution & talentOn track
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Sales deck · value proposition
Win the Defibrinated Animal Blood Market conversation — a $12.2B market you can size, segment and defend in minutes.
Market size · 2033$12.2Btotal opportunity
Growth11.1%CAGR to 2033
Addressable buyers1,777+accounts in scope
Typical ROI7.2×in year one
Who buys (target personas)
§1.1 · p.4 →Product / BU leader
Head of Animal Source
Goal Grow share in Animal Source
Pain Blind spots on demand, pricing & competitors.
Regional GM
North America lead
Goal Prioritise the right markets
Pain No granular, country-level view of the market.
M&A / strategy
Strategy & Corp Dev
Goal Find where to invest or acquire
Pain Slow, inconsistent third-party research.
From pain to solution
§1.2 · p.6 →Decisions made on stale, generic dataLive, source-cited figures, continuously updated
Weeks waiting on a research vendorA full report compiled in minutes
No view of competitors or whitespaceCompany profiles, ACE matrix & benchmarking
Hard to defend the numbers internallyEvery figure traceable to its original source
The business case (ROI)
Fig. 2 · p.9 →7.2×return on cost, year one
< 3 mopayback period
$77K+research cost avoided
10×faster than a custom study
Time to insight
Cost to run
Risk of a wrong call
Why buyers trust it (proof points)
§1.3 · p.12 →600K+source studies indexed
100%analyst-reviewed
15+players profiled in this market
Coverage includes
Thermo Fisher ScientificBio-Rad LaboratoriesMerck KGaA (MilliporeSigma)Charles River LaboratoriesSartorius AGGE Healthcare Life SciencesLonza Group AGPAA Laboratories GmbH+7 more
Objection handling
§1.4 · p.14 →“We already have market data.”
This triangulates 600K+ sources into one current, defensible view — not another silo.
“How do we know it’s accurate?”
Analyst-reviewed, and every figure is source-cited and traceable to its origin.
“It’s not in the budget.”
A fraction of a single analyst-day — and it pays back on the first decision it informs.
“We need it tailored to us.”
Choose the chapters, regions and companies before you build — you only pay for scope.
What you get (packages)
§1.5 · p.16 →Report
- Full multi-chapter report
- Market size, share & forecast
- Segment & regional breakdowns
- PDF + editable Excel + PPT
Most popular
Report + Add-ons
- Everything in Report
- Interactive Visualizer
- Competitive benchmarking
- Investor / board / sales decks
Enterprise
- Multiple reports & markets
- Team seats & sharing
- Analyst support & custom scope
- API / data-feed options
Almost there
Access your Defibrinated Animal Blood Market report
Sign in to unlock the full report - it’s compiled live and ready in minutes.
or continue with your email
Your report is ready to access
Defibrinated Animal Blood Market Report is ready
Verify your email to unlock it. We sent a 6-digit code to your inbox.
That code is invalid or expired. Please try again.
Trusted by strategy, finance & consulting teams
Related Reports
Consumer Goods · scroll →Calamus Essential Oil Market
Market size, share, segmentation and regional forecast.
$3.3B market · 2025 base year
View reportInfrared Heating Pad Market
Market size, share, segmentation and regional forecast.
$388M market · 2025 base year
View reportBaby Health Products Market
Market size, share, segmentation and regional forecast.
$4.9B market · 2025 base year
View reportReusable Cold Gel Packs Market
Market size, share, segmentation and regional forecast.
$364M market · 2025 base year
View reportSmart Textiles for Medicine and Healthcare Market
Market size, share, segmentation and regional forecast.
$2.3B market · 2025 base year
View reportZirconia Ceramics for Dental Restorations Market
Market size, share, segmentation and regional forecast.
$5.4B market · 2025 base year
View reportScalp Follicle Tester Market
Market size, share, segmentation and regional forecast.
$5.0B market · 2025 base year
View reportPlasma Beauty Device Market
Market size, share, segmentation and regional forecast.
$4.5B market · 2025 base year
View reportWall Mounted UV Air Sterilizer Market
Market size, share, segmentation and regional forecast.
$750M market · 2025 base year
View reportCO2 Fractional Laser System Market
Market size, share, segmentation and regional forecast.
$5.9B market · 2025 base year
View reportHolographic Paper Label Market
Market size, share, segmentation and regional forecast.
$5.2B market · 2025 base year
View reportManual Spice Grinder Market
Market size, share, segmentation and regional forecast.
$2.3B market · 2025 base year
View reportThe showdown
Custom-built vs. off-the-shelf
Scroll to watch them go head-to-head
WinnerVMR Custom Report
- Tailored to your exact scope
- Delivered in minutes
- Live, always-current data
- Fully editable data (XLSX)
- You choose the companies
- Source-cited & traceable
Off-the-shelf PDF
- Generic, one-size template
- Waits 2–5 days
- A fixed snapshot in time
- Locked, flat PDF
- Preset company list
- Opaque sourcing
Customer Testimonials
Proof from industry leaders who rely on us
These stories come from the executives who depend on VMR’s intelligence for market entry, expansion, assessment, and planning. Their outcomes and experiences reflect our commitment to clarity.
600,000+source studies indexed
100%analyst-reviewed
Every figuresource-cited & traceable
In their words
Watch clients tell their story
How VMR helped University of Limerick with Anesthesia Monitoring Devices
How VMR helps brands expand into Africa & emerging markets
Unlock your GTM strategy: an Elsewedy Electric success story
Beyond sales data: layering NielsenIQ data to support strategy
How VMR became the trusted partner for United Alloy
Questions, answered
How is the research actually conducted?
Every report is compiled from VMR’s continuously-updated intelligence across 600,000+ source studies - primary interviews, company filings, trade data, and government & industry databases. Figures are triangulated across multiple credible sources, then reviewed by a research analyst before your report is delivered.
What exactly do I get inside the report?
A full multi-chapter study: market definition & methodology, executive summary, market outlook (drivers, restraints, trends, Porter’s Five Forces), segment deep-dives, regional & country breakdowns, competitive landscape, and a full profile for every company you select - with interactive charts and data tables throughout.
How accurate are the numbers, and can I trust them?
Market sizing is reconciled across leading sources (Gartner, BCG, MarketsandMarkets, government bodies and more), with outliers removed and a confidence-graded median used for the base year. Every figure is source-cited and traceable to its origin, and an analyst validates the model before delivery.
Can I customise the chapters, regions and companies?
Yes. Choose exactly the chapters, regions and countries, and the companies you want benchmarked before you build - then adjust your selection and recompile anytime from your account. You only pay for the scope you need.
What formats do I receive, and is the data editable?
Every report is readable online in full. Downloadable formats are available as optional $99 add-ons: a formatted PDF and a fully editable XLSX containing all underlying data tables - so you can re-chart, re-model, or drop any figure straight into your own deck.